Literature DB >> 29216638

MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.

Guo-Yi Wu1,2, Chen Rui3, Ji-Qiao Chen3, Eiketsu Sho3, Shan-Shan Zhan1,2, Xian-Wen Yuan1,2, Yi-Tao Ding1,2.   

Abstract

BACKGROUND/AIMS: An increase in intracellular lipid droplet formation and hepatic triglyceride (TG) content usually results in nonalcoholic fatty liver disease. However, the mechanisms underlying the regulation of hepatic TG homeostasis remain unclear.
METHODS: Oil red O staining and TG measurement were performed to determine the lipid content. miRNA expression was evaluated by quantitative PCR. A luciferase assay was performed to validate the regulation of Yin Yang 1 (YY1) by microRNA (miR)-122. The effects of miR-122 expression on YY1 and its mechanisms involving the farnesoid X receptor and small heterodimer partner (FXR-SHP) pathway were evaluated by quantitative PCR and Western blot analyses.
RESULTS: miR-122 was downregulated in free fatty acid (FFA)-induced steatotic hepatocytes, and streptozotocin and high-fat diet (STZ-HFD) induced nonalcoholic steatohepatitis (NASH) in mice. Transfection of hepatocytes with miR-122 mimics before FFA induction inhibited lipid droplet formation and TG accumulation in vitro. These results were verified by overexpressing miR-122 in the livers of STZ-HFD-induced NASH mice. The 3'-untranslated region (3'UTR) of YY1 mRNA is predicted to contain an evolutionarily conserved miR-122 binding site. In silico searches, a luciferase reporter assay and quantitative PCR analysis confirmed that miR-122 directly bound to the YY1 3'UTR to negatively regulate YY1 mRNA in HepG2 and Huh7 cells. The (FXR-SHP) signaling axis, which is downstream of YY1, may play a key role in the mechanism of miR-122-regulated lipid homeostasis. YY1-FXR-SHP signaling, which is negatively regulated by FFA, was enhanced by miR-122 overexpression. This finding was also confirmed by overexpression of miR-122 in the livers of NASH mice.
CONCLUSIONS: The present results indicate that miR-122 plays an important role in lipid (particularly TG) accumulation in the liver by reducing YY1 mRNA stability to upregulate FXR-SHP signaling.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cell signaling; Fatty Acid/Metabolism; Nonalcoholic Fatty Liver Disease; Triglycerides; Yin Yang 1

Mesh:

Substances:

Year:  2017        PMID: 29216638     DOI: 10.1159/000485765

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  18 in total

1.  [Correlation between serum microRNA-122 and insulin resistance in obese children].

Authors:  Qiong Chen; Yao-Dong Zhang; Sheng-Nan Wu; Yong-Xing Chen; Xiao-Jing Liu; Hai-Yan Wei
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-09

2.  Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.

Authors:  Lei Du; Xuan Qian; Yuan Li; Xi-Zhi Li; Lin-Lin He; Liu Xu; Yi-Qi Liu; Cheng-Cheng Li; Pu Ma; Fang-Lin Shu; Qian Lu; Xiao-Xing Yin
Journal:  Acta Pharmacol Sin       Date:  2020-06-17       Impact factor: 6.150

Review 3.  Non-coding RNA crosstalk with nuclear receptors in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Suthat Liangpunsakul; Li Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-24       Impact factor: 5.187

4.  Hepatic microRNA modulation might be an early event to non-alcoholic fatty liver disease development driven by high-fat diet in male mice.

Authors:  Carolina Panzarin; Laís Angélica de Paula Simino; Mariana Camargo Silva Mancini; Leticia Martins Ignácio-Souza; Marciane Milanski; Márcio Alberto Torsoni; Adriana Souza Torsoni
Journal:  Mol Biol Rep       Date:  2022-01-20       Impact factor: 2.316

5.  MicroRNA Expression Profiling of Bone Marrow Mesenchymal Stem Cells in Steroid-Induced Osteonecrosis of the Femoral Head Associated with Osteogenesis.

Authors:  Ao Wang; Ming Ren; Yang Song; Xiaonan Wang; Qingyu Wang; Qiwei Yang; He Liu; Zhenwu Du; Guizhen Zhang; Jincheng Wang
Journal:  Med Sci Monit       Date:  2018-03-28

6.  miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.

Authors:  Hossein Sendi; Ivy Mead; Meimei Wan; Marjan Mehrab-Mohseni; Kenneth Koch; Anthony Atala; Herbert L Bonkovsky; Colin E Bishop
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

7.  miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.

Authors:  Jun-Ke Long; Wen Dai; Ya-Wen Zheng; Shui-Ping Zhao
Journal:  Mol Med       Date:  2019-06-13       Impact factor: 6.354

8.  Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis.

Authors:  Shenghui Chen; Dan Chen; Hua Yang; Xinyu Wang; Jinghua Wang; Chengfu Xu
Journal:  BMC Gastroenterol       Date:  2020-02-18       Impact factor: 3.067

Review 9.  The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond.

Authors:  Hung-Yu Lin; Ya-Ling Yang; Pei-Wen Wang; Feng-Sheng Wang; Ying-Hsien Huang
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

Review 10.  Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease.

Authors:  Jorge-Luis Torres; Ignacio Novo-Veleiro; Laura Manzanedo; Lucía Alvela-Suárez; Ronald Macías; Francisco-Javier Laso; Miguel Marcos
Journal:  World J Gastroenterol       Date:  2018-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.